is glp 3 and retatrutide the same GLP-1? Helpful. GLP-2? Amazing. GLP-3? 𝗔 𝘄𝗵𝗼𝗹𝗲 𝗻𝗲𝘄 𝗹𝗲𝘃𝗲𝗹 Meet — next generation in medical weight loss. Often called a “ GLP-3”, this new peptide mimics three natural metabolic hormones, not New GLP-3 drug significantly slashes

Multifaced nature of Yohimbinea promising therapeutic potential or a risk

The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care

Drug Company Description Current Phase Mechanism SMALL MOLECULES Orforglipron Eli Lilly First oral small molecule GLP-1 receptor agonist with no food/water restrictions

Prospective Covariate Control: Designing adequately powered prospective longitudinal studies capable of testing whether baseline microbial signatures predict treatment outcomes while strictly controlling for diet, metformin use, and weight loss dynamics

47 Richy, F., Schacht, E., Bruyere, O., Ethgen, O., Gourlay, M., and Reginster, J

Summary: GLP-1 receptor agonists are associated with an increased incidence of cholesterol gallstones, likely due to rapid weight loss and reduced gallbladder motility